Skip to content

Transcelerate RWD Audit Readiness: Data Service Provider Survey – Detailed Report

The intention of the survey is to help answer: ‘What should sponsors and organizations who provide RWD for research purposes consider when preparing for audits in order to help establish relevance and reliability of RWD in a way that is meaningful to regulatory auditors?’ from the perspective of organizations who provide RWD for research purposes. 

Related Blog Posts

Unifying Industry to Better Understand GCP Guidance

In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate…

Unsure About The New ICH Guidelines? TransCelerate Debuts 13 Tools To Help

If you’ve begun combing through the new ICH GCP E6(R3) guidelines to understand how the updates will affect your clinical research practices and feel just a little lost or overwhelmed, you’ve got help. TransCelerate BioPharma, in a partnership with the Association of Clinical Research Organizations (ACRO), has designed and released 13 tools to support E6(R3) adoption across…